CD46 Protects against Chronic Obstructive Pulmonary Disease
Author Information
Author(s): Grumelli Sandra, Lu Bao, Peterson Leif, Maeno Toshitaka, Gerard Craig
Primary Institution: Brigham and Women's Hospital, Harvard Medical School
Hypothesis
A sub-set of ex-smokers with COPD has an autoimmune disease to elastin that impairs inflammation clearance.
Conclusion
Higher expression of CD46 in the lungs of ex-smokers protects them from emphysema and COPD by clearing inflammation.
Supporting Evidence
- CD46 expression was significantly lower in patients with emphysema compared to controls.
- 43% of patients with early onset COPD tested positive for IgG to elastin.
- Decreased CD4+ T cells were associated with lower CD46 expression.
Takeaway
This study found that a protein called CD46 helps protect ex-smokers from serious lung problems by keeping their immune system working well.
Methodology
The study used microarrays and flow cytometry to analyze gene expression in lung tissue from ex-smokers with and without COPD.
Potential Biases
Potential bias due to the selection of participants and the specific focus on ex-smokers.
Limitations
The study may not account for all variables affecting lung health, such as genetic differences or environmental factors.
Participant Demographics
Participants included 87 ex-smokers, with varying degrees of COPD and emphysema, aged 60-68.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website